Author: Olivia Dimmer
-
Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma
Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.
-
Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer
Combining a new hormone therapy drug with chemotherapy and another hormone therapy increased overall survival in patients with high-volume and both high-risk and low-risk metastatic hormone-sensitive prostate cancer, according to a post hoc analysis published in the Journal of Clinical Oncology.
-
New Directions for HIV Treatment
Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.
-
Celebrating Feinberg’s 2023 Match Day
Years of anticipation erupted in a flurry of torn envelopes on Friday as fourth-year Feinberg medical students found out about their residency matches during this year’s Match Day celebration.
-
Predicting Risk of Blood Clots in Brain Tumors
Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.
-
Understanding How Exercise Induces Systemic Metabolic Benefits
Northwestern Medicine scientists have uncovered a mechanism by which exercise activates metabolic benefits in the body, according to a new study published in Cell Metabolism.
-
Future Directions in Continuing Medical Education
Melissa Bregger, MD, FACP, and Clara Schroedl, MD, MS, provide an update on their vision for continuing medical education at Feinberg.
-
Medical Student Discusses Helping a Patient Communicate
Caroline Zhao, a fourth-year medical student at Feinberg, wrote about her experiences assisting a patient with a language barrier in the journal Academic Medicine.
-
Studying the Impact of Stem Cell Transplants
People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.
-
Understanding the Role of Long-Lived Mitochondrial Proteins
Ewa Bomba-Warczak, PhD, is employing metabolic stable isotope pulse-chase labelling and high-resolution shotgun mass spectrometry to track and characterize long-lived mitochondrial proteins in the brain throughout a mouse’s lifespan.
